On Wednesday, Shares of TJX Companies Inc (NYSE:TJX), lost -2.46% to $74.89.
The TJX Companies, declared sales and earnings results for the second quarter ended August 1, 2015. Net sales for the second quarter of Fiscal 2016 raised 6% to $7.4 billion and merged comparable store sales raised 6% over last year’s 3% enhance. Net income for the second quarter was $549 million and diluted earnings per share were $.80, a 7% enhance over the preceding year’s adjusted $.75, which excluded a $.02 per share debt extinguishment charge from stated earnings per share of $.73.
For the first half of Fiscal 2016, net sales were $14.2 billion, a 6% enhance over last year. Merged comparable store sales for the first half of Fiscal 2016 raised 5%. Net income for the first half of Fiscal 2016 was $1.0 billion. Diluted earnings per share were $1.49, an 8% enhance over the preceding year’s adjusted $1.38, which excluded a $.01 per share debt extinguishment charge from stated earnings per share of $1.37.
The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe.
Shares of Comcast Corporation (NASDAQ:CMCSK), inclined 0.58% to $60.46, during its last trading session.
Comcast, in partnership with Khan Academy, a nonprofit on a mission to provide a free, world-class education for anyone, anywhere, celebrated students from the City of Oakland for their achievement in Khan Academy’s recent Bay Area learning challenge, LearnStorm2015.
Comcast introduced new eligibility criteria for Internet Essentials, the nation’s largest and most comprehensive high-speed Internet adoption program. The Company expanded its instant approval process to all families whose children attend schools where fifty percent or more students take part in the National School Lunch Program. All public schools in Oakland meet this new test. As a result, all public school students in the City of Oakland will be instantly approved when they apply for the program, offered they meet the other eligibility criteria.
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand name.
Finally, Tobira Therapeutics Inc (NASDAQ:TBRA), ended its last trade with 2.48% gain, and closed at $13.24.
Tobira Therapeutics declared the enrollment of the first patient into the Phase 2a ORION study. ORION is a randomized, double-blind, placebo-controlled study evaluating the treatment effects of cenicriviroc (CVC) in about 50 obese adults (BMI ≥ 30 kg/m2) with prediabetes or diabetes and suspected non-alcoholic fatty liver disease (NAFLD). The primary outcome of ORION will measure changes in insulin sensitivity in peripheral and adipose tissue over a 24-week period and will comprise an interim analysis at 12 weeks.
The over-expression of CCR2 and CCR5 receptors and their ligands in fat tissue of obese patients has been shown to promote inflammation and enhance insulin resistance. Insulin resistance is associated with the development of NAFLD and is a key driver for disease progression to its more severe form, non-alcoholic steatohepatitis (NASH), in addition to other diabetes related complications.
“The ORION study will assist us to further understand the full spectrum of potential activity of CVC along the continuum of fatty liver disease. We expect interim data from ORION in the first half of 2016,” said Laurent Fischer, M.D., chief executive officer of Tobira Therapeutics.
Tobira Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis, and human immunodeficiency virus (HIV-1).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
